Type I interferons in infectious disease
Open accessAbstract
Type I interferons (IFNs) have diverse effects on innate and adaptive immune cells during infection with viruses, bacteria, parasites and fungi, directly and/or indirectly through the induction of other mediators. Type I IFNs are important for host defence against viruses. However, recently, they have been shown to cause immunopathology in some acute viral infections, such as influenza virus infection. Conversely, they can lead to immunosuppression during chronic viral infections, such as lymphocytic choriomeningitis virus infection. During bacterial infections, low levels of type I IFNs may be required at an early stage, to initiate cell-mediated immune responses. High concentrations of type I IFNs may block B cell responses or lead to the production of immunosuppressive molecules, and such concentrations also reduce the responsiveness of macrophages to activation by IFNγ, as has been shown for infections with Listeria monocytogenes and Mycobacterium tuberculosis. Recent studies in experimental models of tuberculosis have demonstrated that prostaglandin E2 and interleukin-1 inhibit type I IFN expression and its downstream effects, demonstrating that a cross-regulatory network of cytokines operates during infectious diseases to provide protection with minimum damage to the host.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
If type I interferons are present early and properly localized to infection sites, they can limit viral propagation and support macrophage activation, dendritic cell antigen presentation and enhanced antiviral effector T cell responses.
“If type I IFNs are present early and properly localized to sites of infection, they can effectively limit viral propagation, as type I IFNs are responsible for optimal activation of macrophages, antigen presentation by DCs, and enhanced anti-viral effector T cell responses106.”
From SARS-CoV-2, COVID-19 and the aging immune system (2021) · cites this paper as [106]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Role of the microbiota in immunity and inflammation.
Belkaid, Y., & Hand, T. W. (2014) · Cell · doi:10.1016/j.cell.2014.03.011 · Cited by 5,385 · see citing works
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
Gerold, G., & Pietschmann, T. (2014) · Digestive Diseases · doi:10.1159/000360830 · Cited by 4,854 · see citing works
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
Ge, D., Fellay, J., Thompson, A. J. V., Simon, J. S., Shianna, K. V., Urban, T. J., Heinzen, E. L., Qiu, P., Bertelsen, A. H., Muir, A. J., et al. (2009) · Nature · doi:10.1038/nature08309 · Cited by 3,510 · see citing works
Regulation of type I interferon responses
Ivashkiv, L. B., & Donlin, L. T. (2013) · Nature reviews. Immunology · doi:10.1038/nri3581 · Cited by 3,311 · see citing works
Functional Role of Type I and Type II Interferons in Antiviral Defense
Müller, U., Steinhoff, U., Reis, L. F. L., Hemmi, S., Pavlovic, J., Zinkernagel, R. M., & Aguet, M. (1994) · Science · doi:10.1126/science.8009221 · Cited by 2,453 · see citing works
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus
Thomas, D. L., Thio, C. L., Martin, M. P., Qi, Y., Ge, D., Ó’hUigín, C., Kidd, J. R., Kídd, K. K., Khakoo, S. I., Alexander, G., et al. (2009) · Nature · doi:10.1038/nature08463 · Cited by 2,147 · see citing works
Tanaka, Y., Nishida, N., Sugiyama, M., Kurosaki, M., Matsuura, K., Sakamoto, N., Nakagawa, M., Korenaga, M., Hino, K., Hige, S., et al. (2009) · Nature Genetics · doi:10.1038/ng.449 · Cited by 2,141 · see citing works
An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis
Berry, M. P. R., Graham, C. M., McNab, F. W., Xu, Z., Bloch, S. A. A., Oni, T., Wilkinson, K. A., Banchereau, R., Skinner, J., Wilkinson, R. J., et al. (2010) · Nature · doi:10.1038/nature09247 · Cited by 1,898 · see citing works
Self-citationIL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy
Study, F. T. H. C., Suppiah, V., Moldovan, M. V., Ahlenstiel, G., Berg, T., Weltman, M., Abate, M. L., Bassendine, M. F., Spengler, U., Dore, G. J., et al. (2009) · Nature Genetics · doi:10.1038/ng.447 · Cited by 1,807 · see citing works
Interferons, interferon‐like cytokines, and their receptors
Pestka, S., Krause, C. D., & Walter, M. R. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00204.x · Cited by 1,768 · see citing works
Regulation of Interferon‐γ During Innate and Adaptive Immune Responses
Schoenborn, J. R., & Wilson, C. B. (2007) · Advances in immunology · doi:10.1016/s0065-2776(07)96002-2 · Cited by 1,659 · see citing works
Morens, D. M., Taubenberger, J. K., & Fauci, A. S. (2008) · The Journal of Infectious Diseases · doi:10.1086/591708 · Cited by 1,625 · see citing works
Type I Inteferon Gene Induction by the Interferon Regulatory Factor Family of Transcription Factors
Honda, K., Takaoka, A., & Taniguchi, T. (2006) · Immunity · doi:10.1016/j.immuni.2006.08.009 · Cited by 1,386 · see citing works
The IRF Family Transcription Factors in Immunity and Oncogenesis
Tamura, T., Yanai, H., Savitsky, D., & Taniguchi, T. (2008) · Annual Review of Immunology · doi:10.1146/annurev.immunol.26.021607.090400 · Cited by 1,259 · see citing works
CD69 acts downstream of interferon-α/β to inhibit S1P1 and lymphocyte egress from lymphoid organs
Shiow, L. R., Rosen, D. B., Brdičková, N., Xu, Y., An, J., Lanier, L. L., Cyster, J. G., & Matloubian, M. (2006) · Nature · doi:10.1038/nature04606 · Cited by 1,189 · see citing works
Commensal bacteria calibrate the activation threshold of innate antiviral immunity
Abt, M. C., Osborne, L. C., Monticelli, L. A., Doering, T. A., Alenghat, T., Sonnenberg, G. F., Paley, M. A., Antenus, M., Williams, K. L., Erikson, J., et al. (2012) · Immunity · doi:10.1016/j.immuni.2012.04.011 · Cited by 993 · see citing works
Bon, A. L., Schiavoni, G., D’Agostino, G., Gresser, I., Belardelli, F., & Tough, D. F. (2001) · Immunity · doi:10.1016/s1074-7613(01)00126-1 · Cited by 973 · see citing works
Kolumam, G. A., Thomas, S., Thompson, L. J., Sprent, J., & Murali‐Krishna, K. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050821 · Cited by 967 · see citing works
Prokunina‐Olsson, L., Muchmore, B., Tang, W., Pfeiffer, R. M., Park, H., Dickensheets, H. L., Hergott, D., Porter-Gill, P. A., Mumy, A., Kohaar, I., et al. (2013) · Nature Genetics · doi:10.1038/ng.2521 · Cited by 929 · see citing works
Type I Interferon Inhibits Interleukin-1 Production and Inflammasome Activation
Guarda, G., Braun, M., Staehli, F., Tardivel, A., Mattmann, C., Förster, I., Farlik, M., Decker, T., Pasquier, R. D., Romero, P. J., et al. (2011) · Immunity · doi:10.1016/j.immuni.2011.02.006 · Cited by 924 · see citing works
Dendritic Cells Prime Natural Killer Cells by trans-Presenting Interleukin 15
Lucas, M., Schachterle, W., Oberle, K., Aichele, P., & Diefenbach, A. (2007) · Immunity · doi:10.1016/j.immuni.2007.03.006 · Cited by 888 · see citing works
Goubau, D., Deddouche, S., & Sousa, C. R. E. (2013) · Immunity · doi:10.1016/j.immuni.2013.05.007 · Cited by 847 · see citing works
Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon
Bon, A. L., Etchart, N., Rossmann, C., Ashton, M., Hou, S., Gewert, D. R., Borrow, P., & Tough, D. F. (2003) · Nature Immunology · doi:10.1038/ni978 · Cited by 816 · see citing works
Liu, L., Okada, S., Kong, X., Kreins, A. Y., Cypowyj, S., Abhyankar, A., Toubiana, J., Itan, Y., Audry, M., Nitschké, P., et al. (2011) · The Journal of Experimental Medicine · doi:10.1084/jem.20110958 · Cited by 799 · see citing works
IFITM3 restricts the morbidity and mortality associated with influenza
The GenISIS Investigators, Everitt, A. R., The MOSAIC Investigators, Clare, S., Pertel, T., John, S. P., Wash, R. S., Smith, S. E., Chin, C. R., Feeley, E. M., et al. (2012) · Nature · doi:10.1038/nature10921 · Cited by 783 · see citing works
Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk
Mayer-Barber, K. D., Andrade, B. B., Oland, S. D., Amaral, E. P., Barber, D. L., Gonzales, J., Derrick, S. C., Shi, R., Kumar, N. P., Wei, W., et al. (2014) · Nature · doi:10.1038/nature13489 · Cited by 770 · see citing works
Self-citationPaludan, S. R., & Bowie, A. (2013) · Immunity · doi:10.1016/j.immuni.2013.05.004 · Cited by 764 · see citing works
Type I Interferons Keep Activated T Cells Alive
Marrack, P., Kappler, J. W., & Mitchell, T. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.3.521 · Cited by 763 · see citing works
Persistent LCMV infection is controlled by blockade of type I interferon signaling
Teijaro, J. R., Ng, C., Lee, A. M., Sullivan, B. M., Sheehan, K. C. F., Welch, M., Schreiber, R. D., Carlos de la Torre, J., & Oldstone, M. B. A. (2013) · Science · doi:10.1126/science.1235214 · Cited by 755 · see citing works
The AIM2 inflammasome is critical for innate immunity to Francisella tularensis
Fernandes-Alnemri, T., Yu, J.-W., Juliana, C., Solorzano, L., Kang, S., Wu, J., Datta, P., McCormick, M., Huang, L., McDermott, E., et al. (2010) · Nature Immunology · doi:10.1038/ni.1859 · Cited by 732 · see citing works
TRIF Licenses Caspase-11-Dependent NLRP3 Inflammasome Activation by Gram-Negative Bacteria
Rathinam, V. A. K., Vanaja, S. K., Waggoner, L., Sokolovska, A., Becker, C., Stuart, L. M., Leong, J. M., & Fitzgerald, K. A. (2012) · Cell · doi:10.1016/j.cell.2012.07.007 · Cited by 729 · see citing works
Blockade of chronic type I interferon signaling to control persistent LCMV infection
Wilson, E. B., Yamada, D. H., Elsaesser, H., Herskovitz, J., Deng, J., Cheng, G., Aronow, B. J., Karp, C. L., & Brooks, D. G. (2013) · Science · doi:10.1126/science.1235208 · Cited by 709 · see citing works
Interferons α and β as Immune Regulators—A New Look
Biron, C. A. (2001) · Immunity · doi:10.1016/s1074-7613(01)00154-6 · Cited by 670 · see citing works
STAT1 Mutations in Autosomal Dominant Chronic Mucocutaneous Candidiasis
van de Veerdonk, F. L., Plantinga, T. S., Hoischen, A., Smeekens, S. P., Joosten, L. A. B., Gilissen, C., Arts, P., Rosentul, D. C., Carmichael, A., der Graaf, C. A. A. S.-V., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1100102 · Cited by 665 · see citing works
Santini, S. M., Lapenta, C., Logozzi, M., Parlato, S., Spada, M., Pucchio, T. D., & Belardelli, F. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.10.1777 · Cited by 644 · see citing works
Curtsinger, J., Valenzuela, J. O., Agarwal, P., Lins, D. C., & Mescher, M. F. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.8.4465 · Cited by 633 · see citing works
Nguyen, K. B., Salazar‐Mather, T. P., Dalod, M., VanDeusen, J. B., Wei, X., Liew, F. Y., Caligiuri, M. A., Durbin, J. E., & Biron, C. A. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.8.4279 · Cited by 606 · see citing works
Manca, C., Tsenova, L., Bergtold, A., Freeman, S. L., Tovey, M. G., Musser, J. M., Barry, C. E., Freedman, V. H., & Kaplan, G. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091096998 · Cited by 590 · see citing works
Mycobacterial Disease and Impaired IFN-γ Immunity in Humans with Inherited ISG15 Deficiency
Bogunovic, D., Byun, M., Durfee, L. A., Abhyankar, A., Sanal, O., Mansouri, D., Salem, S., Radovanovic, I., Grant, A. V., Adimi, P., et al. (2012) · Science · doi:10.1126/science.1224026 · Cited by 572 · see citing works
Interferon-inducible effector mechanisms in cell-autonomous immunity
MacMicking, J. D. (2012) · Nature reviews. Immunology · doi:10.1038/nri3210 · Cited by 564 · see citing works
Bromberg, J., Horvath, C. M., Wen, Z., Schreiber, R. D., & Darnell, J. E., Jr. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.15.7673 · Cited by 541 · see citing works
Gautier, G., Humbert, M., Deauvieau, F., Scuiller, M., Hiscott, J. B., Bates, E. E. M., Trinchieri, G., Caux, C., & Garrone, P. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041964 · Cited by 537 · see citing works
Yan, N., & Chen, Z. J. (2012) · Nature Immunology · doi:10.1038/ni.2229 · Cited by 535 · see citing works
Caspase-11 increases susceptibility to Salmonella infection in the absence of caspase-1
Broz, P., Ruby, T., Belhocine, K., Bouley, D. M., Kayagaki, N., Dixit, V. M., & Monack, D. M. (2012) · Nature · doi:10.1038/nature11419 · Cited by 535 · see citing works
Type I interferons produced by dendritic cells promote their phenotypic and functional activation
Montoya, M., Schiavoni, G., Mattei, F., Gresser, I., Belardelli, F., Borrow, P., & Tough, D. F. (2002) · Blood · doi:10.1182/blood.v99.9.3263 · Cited by 534 · see citing works
Interferon alpha increases the frequency of interferon gamma-producing human CD4+ T cells.
Brinkmann, V., Geiger, T. M., Alkan, Ş. Ş., & Heusser, C. H. (1993) · The Journal of Experimental Medicine · doi:10.1084/jem.178.5.1655 · Cited by 505 · see citing works
Nguyen, K. B., Watford, W. T., Salomon, R., Hofmann, S. R., Pien, G. C., Morinobu, A., Gadina, M., O’Shea, J. J., & Biron, C. A. (2002) · Science · doi:10.1126/science.1074900 · Cited by 495 · see citing works
Type I Interferon Production Enhances Susceptibility to Listeria monocytogenes Infection
O’Connell, R. M., Saha, S. K., Vaidya, S. A., Bruhn, K. W., Miranda, G. A., Zarnegar, B. J., Perry, A. K., Nguyen, B. D., Lane, T. F., Taniguchi, T., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040712 · Cited by 489 · see citing works
Ganal, S. C., Sanos, S. L., Kallfass, C., Oberle, K., Johner, C., Kirschning, C., Lienenklaus, S., Weiss, S., Staeheli, P., Aichele, P., et al. (2012) · Immunity · doi:10.1016/j.immuni.2012.05.020 · Cited by 484 · see citing works
Jacquelin, B., Mayau, V., Targat, B., Liovat, A.-S., Kunkel, D., Petitjean, G., Dillies, M., Roques, P., Butor, C., Silvestri, G., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci40093 · Cited by 480 · see citing works
Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice
Shahangian, A., Chow, E. K., Tian, X., Kang, J. R., Ghaffari, A., Liu, S. Y., Belperio, J. A., Cheng, G., & Deng, J. C. (2009) · Journal of Clinical Investigation · doi:10.1172/jci35412 · Cited by 479 · see citing works
Constitutive Type I Interferon Modulates Homeostatic Balance through Tonic Signaling
Gough, D. J., Messina, N. L., Clarke, C. J. P., Johnstone, R. W., & Levy, D. E. (2012) · Immunity · doi:10.1016/j.immuni.2012.01.011 · Cited by 472 · see citing works
Mayer-Barber, K. D., Barber, D. L., Shenderov, K., White, S., Wilson, M. S., Cheever, A. W., Kugler, D. G., Hieny, S. E., Caspar, P., Núñez, G., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0904189 · Cited by 472 · see citing works
Self-citationInterferon α/β and Interleukin 12 Responses to Viral Infections
Dalod, M., Salazar‐Mather, T. P., Malmgaard, L., Lewis, C. A., Asselin‐Paturel, C., Brière, F., Trinchieri, G., & Biron, C. A. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011672 · Cited by 462 · see citing works
Type I interferon responses in rhesus macaques prevent SIV infection and slow disease progression
Utay, N. S., Bosinger, S. E., Estes, J. D., Zhu, R. T., Tharp, G. K., Boritz, E., Levin, D., Wijeyesinghe, S., Nganou‐Makamdop, K., Prete, G. Q. D., et al. (2014) · Nature · doi:10.1038/nature13554 · Cited by 458 · see citing works
Mice Lacking the Type I Interferon Receptor Are Resistant to Listeria monocytogenes
Auerbuch, V., Brockstedt, D. G., Meyer-Morse, N., O’Riordan, M. X., & Portnoy, D. A. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040976 · Cited by 451 · see citing works
Mordstein, M., Neugebauer, E., Ditt, V., Jessen, B., Rieger, T., Falcone, V., Sorgeloos, F., Ehl, S. R., Mayer, D., Kochs, G., et al. (2010) · Journal of Virology · doi:10.1128/jvi.00272-10 · Cited by 447 · see citing works
Stanley, S. A., Johndrow, J. E., Manzanillo, P. S., & Cox, J. S. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.5.3143 · Cited by 439 · see citing works
Robinson, N., McComb, S., Mulligan, R., Dudani, R., Krishnan, L., & Sad, S. (2012) · Nature Immunology · doi:10.1038/ni.2397 · Cited by 438 · see citing works
Mayer-Barber, K. D., Andrade, B. B., Barber, D. L., Hieny, S., Feng, C. G., Caspar, P., Oland, S., Gordon, S., & Sher, A. (2011) · Immunity · doi:10.1016/j.immuni.2011.12.002 · Cited by 418 · see citing works
Self-citationType I Interferon Sensitizes Lymphocytes to Apoptosis and Reduces Resistance to Listeria Infection
Carrero, J. A., Calderón, B., & Unanue, E. R. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040769 · Cited by 390 · see citing works
Mandl, J. N., Barry, A. P., Vanderford, T. H., Kozyr, N. L., Chavan, R., Klucking, S., Barrat, F. J., Coffman, R. L., Staprans, S. I., & Feinberg, M. B. (2008) · Nature Medicine · doi:10.1038/nm.1871 · Cited by 382 · see citing works
Type I Interferon Suppresses Type II Interferon–Triggered Human Anti-Mycobacterial Responses
Teles, R. M. B., Graeber, T. G., Krutzik, S. R., Montoya, D. J., Schenk, M., Lee, D. J., Komisopoulou, E., Kelly‐Scumpia, K. M., Chun, R. F., Iyer, S. S., et al. (2013) · Science · doi:10.1126/science.1233665 · Cited by 381 · see citing works
Herold, S., Steinmueller, M., von Wulffen, W., Cakarova, L., Pinto, R., Pleschka, S., Mack, M., Kuziel, W. A., Corazza, N., Brunner, T., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080201 · Cited by 376 · see citing works
Pathogenic potential of interferon αβ in acute influenza infection
Davidson, S., Crotta, S., McCabe, T. M., & Wack, A. (2014) · Nature Communications · doi:10.1038/ncomms4864 · Cited by 370 · see citing works
Self-citationDiefenbach, A., Schindler, H., Donhauser, N., Lorenz, E., Laskay, T., MacMicking, J. D., Röllinghoff, M., Gresser, I., & Bogdan, C. (1998) · Immunity · doi:10.1016/s1074-7613(00)80460-4 · Cited by 368 · see citing works
Bon, A. L., Thompson, C., Kamphuis, E., Durand, V., Rossmann, C., Kalinke, U., & Tough, D. F. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.4.2074 · Cited by 361 · see citing works
TLR signalling and activation of IRFs: revisiting old friends from the NF-κB pathway
Moynagh, P. N. (2005) · Trends in Immunology · doi:10.1016/j.it.2005.06.009 · Cited by 336 · see citing works
Mordstein, M., Kochs, G., Dumoutier, L., Renauld, J., Paludan, S. R., Klucher, K. M., & Staeheli, P. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000151 · Cited by 326 · see citing works
Henry, T., Brotcke, A., Weiss, D. S., Thompson, L. J., & Monack, D. M. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062665 · Cited by 323 · see citing works
Inborn Errors of Human JAKs and STATs
Casanova, J., Holland, S. M., & Notarangelo, L. D. (2012) · Immunity · doi:10.1016/j.immuni.2012.03.016 · Cited by 320 · see citing works
Zhang, S., Boisson‐Dupuis, S., Chapgier, A. L. A., Yang, K., Bustamante, J. C., Puel, A., Pïcard, C., Abel, L., Jouanguy, E., & Casanova, J. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00698.x · Cited by 320 · see citing works
Host-cell sensors for Plasmodium activate innate immunity against liver-stage infection
Liehl, P., Zuzarte-Luís, V., Chan, J., Zillinger, T., Baptista, F., Carapau, D., Konert, M., Hanson, K. K., Carret, C., Lassnig, C., et al. (2014) · Nature Medicine · doi:10.1038/nm.3424 · Cited by 313 · see citing works
Differential Regulation of Human Blood Dendritic Cell Subsets by IFNs
Ito, T., Amakawa, R., Inaba, M., Ikehara, S., Inaba, K., & Fukuhara, S. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.5.2961 · Cited by 310 · see citing works
Interferon α/β-mediated inhibition and promotion of interferon γ: STAT1 resolves a paradox
Nguyen, K. B., Cousens, L. P., Doughty, L., Pien, G. C., Durbin, J. E., & Biron, C. A. (2000) · Nature Immunology · doi:10.1038/76940 · Cited by 303 · see citing works
Human gene expression profiles of susceptibility and resistance in tuberculosis
Maertzdorf, J., Repsilber, D., Parida, S. K., Stanley, K., Roberts, T., Black, G. F., Walzl, G., & Kaufmann, S. H. E. (2010) · Genes and Immunity · doi:10.1038/gene.2010.51 · Cited by 300 · see citing works
Cousens, L. P., Orange, J. S., Su, H. C., & Biron, C. A. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.2.634 · Cited by 299 · see citing works
Manca, C., Tsenova, L., Freeman, S. L., Barczak, A. K., Tovey, M. G., Murray, P. J., Barry, C. E., & Kaplan, G. (2005) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2005.25.694 · Cited by 295 · see citing works
Influenza Virus-Susceptible Mice Carry Mx Genes with a Large Deletion or a Nonsense Mutation
Staeheli, P., Grob, R., Meier, E., Sutcliffe, J. G., & Haller, O. (1988) · Molecular and Cellular Biology · doi:10.1128/mcb.8.10.4518-4523.1988 · Cited by 294 · see citing works
Antonelli, L. R. D. V., Rothfuchs, A. G., Gonçalves, R., Roffê, E., Cheever, A. W., Báfica, A. L. B., Salazar, A. Μ., Feng, C. G., & Sher, A. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40817 · Cited by 292 · see citing works
Self-citationPandey, A. K., Yang, Y., Jiang, Z., Fortune, S. M., Coulombe, F., Behr, M. A., Fitzgerald, K. A., Sassetti, C. M., & Kelliher, M. A. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000500 · Cited by 292 · see citing works
Cousens, L. P., Peterson, R. L., Hsu, S., Dorner, A. J., Altman, J. D., Ahmed, R., & Biron, C. A. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.8.1315 · Cited by 290 · see citing works
Type I IFN Modulates Innate and Specific Antiviral Immunity
Durbin, J. E., Fernández-Sesma, A., Lee, C., Rao, T. D., Frey, A. B., Moran, T. M., Vukmanović, S., García‐Sastre, A., & Levy, D. E. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.8.4220 · Cited by 286 · see citing works
The Role of Interferon in Influenza Virus Tissue Tropism
García‐Sastre, A., Durbin, R. K., Zheng, H., Palese, P., Gertner, R., Levy, D. E., & Durbin, J. E. (1998) · Journal of Virology · doi:10.1128/jvi.72.11.8550-8558.1998 · Cited by 286 · see citing works
Direct Stimulation of T Cells by Type I IFN Enhances the CD8+ T Cell Response during Cross-Priming
Bon, A. L., Durand, V., Kamphuis, E., Thompson, C., Bulfone‐Paus, S., Rossmann, C., Kalinke, U., & Tough, D. F. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.8.4682 · Cited by 283 · see citing works
The regulation of inflammation by interferons and their STATs
Rauch, I., Müller, M. M., & Decker, T. (2013) · JAK-STAT · doi:10.4161/jkst.23820 · Cited by 283 · see citing works
Nakamura, S., Davis, K. M., & Weiser, J. N. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57762 · Cited by 280 · see citing works
NOD1 and NOD2 Signaling in Infection and Inflammation
Moreira, L. O., & Zamboni, D. S. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00328 · Cited by 267 · see citing works
Watanabe, T., Asano, N., Fichtner‐Feigl, S., Gorelick, P. L., Tsuji, Y., Matsumoto, Y. M., Chiba, T., Fuss, I. J., Kitani, A., & Strober, W. (2010) · Journal of Clinical Investigation · doi:10.1172/jci39481 · Cited by 265 · see citing works
Tripartite-motif proteins and innate immune regulation
McNab, F. W., Rajsbaum, R., Stoye, J. P., & O’Garra, A. (2010) · Current Opinion in Immunology · doi:10.1016/j.coi.2010.10.021 · Cited by 263 · see citing works
Self-citationCrotta, S., Davidson, S., Mahlakõiv, T., Desmet, C. J., Buckwalter, M. R., Albert, M. L., Staeheli, P., & Wack, A. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003773 · Cited by 263 · see citing works
Self-citationSoudja, S. M., Ruiz, A. L., Marie, J. C., & Lauvau, G. S. (2012) · Immunity · doi:10.1016/j.immuni.2012.05.029 · Cited by 263 · see citing works
Zhang, Y., Zhao, Y., Li, N., Peng, Y., Giannoulatou, E., Jin, R., Yan, H., Wu, H., Liu, J., Liu, N., et al. (2013) · Nature Communications · doi:10.1038/ncomms2433 · Cited by 262 · see citing works
Ordway, D. J., Henao-Tamayo, M. I., Harton, M. R., Palanisamy, G. S., Troudt, J. M., Shanley, C. A., Basaraba, R. J., & Orme, I. M. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.1.522 · Cited by 259 · see citing works
Parlato, S., Santini, S. M., Lapenta, C., Pucchio, T. D., Logozzi, M., Spada, M., Giammarioli, A. M., Malorni, W., Fais, S., & Belardelli, F. (2001) · Blood · doi:10.1182/blood.v98.10.3022 · Cited by 259 · see citing works
Virus or TLR Agonists Induce TRAIL-Mediated Cytotoxic Activity of Plasmacytoid Dendritic Cells
Chaperot, L., Blum, A., Manches, O., Lui, G., Angel, J., Molens, J., & Plumas, J. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.1.248 · Cited by 256 · see citing works
Viral tricks to grid-lock the type I interferon system
Versteeg, G. A., & García‐Sastre, A. (2010) · Current Opinion in Microbiology · doi:10.1016/j.mib.2010.05.009 · Cited by 256 · see citing works
Interferon induces a unique protein in mouse cells bearing a gene for resistance to influenza virus.
Horisberger, M. A., Staeheli, P., & Haller, O. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.7.1910 · Cited by 249 · see citing works
Type I IFN Signaling Is Crucial for Host Resistance against Different Species of Pathogenic Bacteria
Mancuso, G., Midiri, A., Biondo, C., Beninati, C., Zummo, S., Galbo, R., Tomasello, F. F., Gambuzza, M. E., Macrì, G., Ruggeri, A., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.5.3126 · Cited by 248 · see citing works
Novikov, A., Cardone, M., Thompson, R. W., Shenderov, K., Kirschman, K. D., Mayer-Barber, K. D., Myers, T. G., Rabin, R. L., Trinchieri, G., Sher, A., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100926 · Cited by 243 · see citing works
Self-citationCliff, J. M., Lee, J., Constantinou, N., Cho, J.-E., Clark, T. G., Ronacher, K., King, E. C., Lukey, P. T., Duncan, K., van Helden, P. D., et al. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis499 · Cited by 240 · see citing works
Kohlmeier, J. E., Cookenham, T. S., Roberts, A. D., Miller, S. C., & Woodland, D. L. (2010) · Immunity · doi:10.1016/j.immuni.2010.06.016 · Cited by 237 · see citing works
Effects of IL-12 on the response and susceptibility to experimental viral infections.
Orange, J. S., Wolf, S., & Biron, C. A. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.3.1253 · Cited by 235 · see citing works
Ottenhoff, T. H. M., Dass, R. H., Yang, N., Zhang, M. M., Wong, H. E. E., Sahiratmadja, E., Khor, C. C., Alisjahbana, B., van Crevel, R., Marzuki, S., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045839 · Cited by 231 · see citing works
Type I Interferons Protect T Cells against NK Cell Attack Mediated by the Activating Receptor NCR1
Crouse, J., Bedenikovic, G., Wiesel, M., Ibberson, M. R., Xénarios, I., von Laer, D., Kalinke, U., Vivier, É., Jonjić, S., & Oxenius, A. (2014) · Immunity · doi:10.1016/j.immuni.2014.05.003 · Cited by 229 · see citing works
Högner, K., Wolff, T., Pleschka, S., Plog, S., Gruber, A. D., Kalinke, U., Walmrath, H., Bodner, J., Gattenlöhner, S., Lewe-Schlosser, P., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003188 · Cited by 228 · see citing works
Sung, J. H., Zhang, H., Moseman, E. A., Álvarez, D., Iannacone, M., Henrickson, S. E., de la Torre, J. C., Groom, J. R., Luster, A. D., & von Andrian, U. H. (2012) · Cell · doi:10.1016/j.cell.2012.08.015 · Cited by 228 · see citing works
Type I Interferon Protects Antiviral CD8+ T Cells from NK Cell Cytotoxicity
Xu, H. C., Grusdat, M., Pandyra, A. A., Polz, R., Huang, J., Sharma, P., Deenen, R., Köhrer, K., Rahbar, R., Diefenbach, A., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.05.004 · Cited by 227 · see citing works
Distinct TLR- and NLR-Mediated Transcriptional Responses to an Intracellular Pathogen
Leber, J. H., Crimmins, G. T., Raghavan, S., Meyer-Morse, N., Cox, J. S., & Portnoy, D. A. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.0040006 · Cited by 221 · see citing works
Interferon induction and function at the mucosal surface
Durbin, R. K., Kotenko, S. V., & Durbin, J. E. (2013) · Immunological Reviews · doi:10.1111/imr.12101 · Cited by 221 · see citing works
Heer, A. K., Shamshiev, A. T., Donda, A., Uematsu, S., Akira, S., Köpf, M., & Marsland, B. J. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.4.2182 · Cited by 212 · see citing works
Havenar‐Daughton, C., Kolumam, G. A., & Murali‐Krishna, K. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.6.3315 · Cited by 211 · see citing works
Herbeuval, J. (2005) · Blood · doi:10.1182/blood-2005-03-1243 · Cited by 211 · see citing works
Hahm, B., Trifilo, M. J., Zúñiga, E. I., & Oldstone, M. B. A. (2005) · Immunity · doi:10.1016/j.immuni.2005.01.005 · Cited by 210 · see citing works
Induction of IFN-αβ enables Listeria monocytogenes to suppress macrophage activation by IFN-γ
Rayamajhi, M., Humann, J., Penheiter, K. L., Andreasen, K., & Lenz, L. L. (2010) · The Journal of Experimental Medicine · doi:10.1084/jem.20091746 · Cited by 209 · see citing works
Coulombe, F., Jaworska, J., Verway, M. J., Tzelepis, F., Massoud, A. H., Gillard, J., Wong, G., Kobinger, G., Xing, Z., Couture, C., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.02.013 · Cited by 207 · see citing works
Orange, J. S., Salazar‐Mather, T. P., Opal, S. M., Spencer, R. L., Miller, A. H., McEwen, B. S., & Biron, C. A. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.181.3.901 · Cited by 207 · see citing works
Kawashima, T., Kosaka, A., Yan, H., Guo, Z., Uchiyama, R., Fukui, R., Kaneko, D., Kumagai, Y., You, D., Carreras, J., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.02.024 · Cited by 206 · see citing works
Agarwal, P., Raghavan, A., Nandiwada, S. L., Curtsinger, J., Bohjanen, P. R., Mueller, D. L., & Mescher, M. F. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900592 · Cited by 203 · see citing works
Protective Role of Beta Interferon in Host Defense against Influenza A Virus
Koerner, I., Kochs, G., Kalinke, U., Weiß, S., & Staeheli, P. (2006) · Journal of Virology · doi:10.1128/jvi.01718-06 · Cited by 201 · see citing works
Attrition of Bystander CD8 T Cells during Virus-Induced T-Cell and Interferon Responses
McNally, J. M., Zarozinski, C. C., Lin, M., Brehm, M. A., Chen, H. D., & Welsh, R. M. (2001) · Journal of Virology · doi:10.1128/jvi.75.13.5965-5976.2001 · Cited by 199 · see citing works
Thompson, L. J., Kolumam, G. A., Thomas, S., & Murali‐Krishna, K. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.3.1746 · Cited by 197 · see citing works
McNab, F. W., Ewbank, J., Howes, A., Moreira-Teixeira, L., Մարտիրոսյան, Ա., Ghilardi, N., Saraiva, M., & O’Garra, A. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1401088 · Cited by 197 · see citing works
Self-citationThe Role of Alpha/Beta and Gamma Interferons in Development of Immunity to Influenza A Virus in Mice
Price, G. E., Gaszewska-Mastarlarz, A., & Moskophidis, D. (2000) · Journal of Virology · doi:10.1128/jvi.74.9.3996-4003.2000 · Cited by 192 · see citing works
Li, W., Moltedo, B., & Moran, T. M. (2012) · Journal of Virology · doi:10.1128/jvi.01269-12 · Cited by 191 · see citing works
del Fresno, C., Soulat, D., Roth, S., Blazek, K. D., Udalova, I. A., Sancho, D., Ruland, J., & Ardavı́n, C. (2013) · Immunity · doi:10.1016/j.immuni.2013.05.010 · Cited by 189 · see citing works
Rotger, M., Dalmau, J., Rauch, A., McLaren, P. J., Bosinger, S. E., Martínez, R., Utay, N. S., Roque, A., Liebner, J. C., Battegay, M., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45235 · Cited by 188 · see citing works
Herbeuval, J., Nilsson, J., Boasso, A., Hardy, A. W., Kruhlak, M. J., Anderson, S. A., Dolan, M. J., Dy, M., Andersson, J., & Shearer, G. M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600363103 · Cited by 186 · see citing works
Coro, E. S., Chang, W. L. W., & Baumgarth, N. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.7.4343 · Cited by 184 · see citing works
Miyagi, T., Gil, M. P., Wang, X., Louten, J., Chu, W., & Biron, C. A. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070401 · Cited by 175 · see citing works
Hardy, A. W., Graham, D. R. M., Shearer, G. M., & Herbeuval, J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707244104 · Cited by 174 · see citing works
Dynamic Roles of Type I and Type II IFNs in Early Infection with Mycobacterium tuberculosis
Desvignes, L., Wolf, A. J., & Ernst, J. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200255 · Cited by 173 · see citing works
Aichele, P., Unsoeld, H., Koschella, M., Schweier, O., Kalinke, U., & Vucikuja, S. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.8.4525 · Cited by 172 · see citing works
Martinez, J., Huang, X., & Yang, Y. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.3.1592 · Cited by 168 · see citing works
IL-28A, IL-28B, and IL-29: Promising cytokines with type I interferon-like properties
Witte, K., Witte, E., Sabat, R., & Wolk, K. (2010) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2010.04.002 · Cited by 167 · see citing works
Impairment of T and B Cell Development by Treatment with a Type I Interferon
Lin, Q., Dong, C., & Cooper, M. D. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.1.79 · Cited by 163 · see citing works
Type I IFN enhances follicular B cell contribution to the T cell–independent antibody response
Swanson, C. L., Wilson, T. J., Strauch, P., Colonna, M., Pelanda, R., & Torres, R. M. (2010) · The Journal of Experimental Medicine · doi:10.1084/jem.20092695 · Cited by 160 · see citing works
Type I IFN Signaling Constrains IL-17A/F Secretion by γδ T Cells during Bacterial Infections
Henry, T., Kirimanjeswara, G. S., Ruby, T., Jones, J. W., Peng, K., Perret, M., Ho, L., Sauer, J., Iwakura, Y., Metzger, D. W., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902065 · Cited by 157 · see citing works
Majer, O., Bourgeois, C., Zwolanek, F., Lassnig, C., Kerjaschki, D., Mack, M., Müller, M., & Kuchler, K. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002811 · Cited by 156 · see citing works
Moseman, E. A., Iannacone, M., Bosurgi, L., Tonti, E., Chevrier, N., Tumanov, A. V., Fu, Y., Hacohen, N., & von Andrian, U. H. (2012) · Immunity · doi:10.1016/j.immuni.2012.01.013 · Cited by 155 · see citing works
Production of Type I IFN Sensitizes Macrophages to Cell Death Induced by Listeria monocytogenes
Stockinger, S., Materna, T., Stoiber, D., Bayr, L., Steinborn, R., Kolbe, T., Unger, H., Chakraborty, T., Levy, D. E., Müller, M. M., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.11.6522 · Cited by 155 · see citing works
Streptococcus pneumoniae DNA Initiates Type I Interferon Signaling in the Respiratory Tract
Parker, D., Martin, F. J., Soong, G., Harfenist, B. S., Aguilar, J. L., Ratner, A. J., Fitzgerald, K. A., Schindler, C., & Prince, A. S. (2011) · mBio · doi:10.1128/mbio.00016-11 · Cited by 151 · see citing works
Antiproliferative action of interferon-α requires components of T-cell-receptor signalling
Petricoin, E. F., Ito, S., Williams, B. L., Audet, S. A., Stancato, L. F., Gamero, A. M., Clouse, K. A., Grimley, P. M., Weiss, A., Beeler, J. A., et al. (1997) · Nature · doi:10.1038/37648 · Cited by 150 · see citing works
Spadaro, F., Lapenta, C., Donati, S., Abalsamo, L., Barnaba, V., Belardelli, F., Santini, S. M., & Ferrantini, M. (2011) · Blood · doi:10.1182/blood-2011-06-363564 · Cited by 150 · see citing works
Cutting Edge: Role of STAT1, STAT3, and STAT5 in IFN-αβ Responses in T Lymphocytes
Tanabe, Y., Nishibori, T., Su, L., Arduini, R. M., Baker, D. P., & David, M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.2.609 · Cited by 148 · see citing works
IFN-λ4: The Paradoxical New Member of the Interferon Lambda Family
OʼBrien, T. R., Prokunina‐Olsson, L., & Donnelly, R. P. (2014) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2013.0136 · Cited by 147 · see citing works
Martin, F. J., Gómez, M. I., Wetzel, D. M., Memmi, G., O’Seaghdha, M., Soong, G., Schindler, C., & Prince, A. S. (2009) · Journal of Clinical Investigation · doi:10.1172/jci35879 · Cited by 147 · see citing works
Lee, C., Smith, E., Gimeno, R., Gertner, R., & Levy, D. E. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.3.1286 · Cited by 145 · see citing works
Increased susceptibility to bacterial superinfection as a consequence of innate antiviral responses
Navarini, A. A., Recher, M., Lang, K. S., Georgiev, P., Meury, S., Bergthaler, A., Flatz, L., Bille, J., Landmann, R., Odermatt, B., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607325103 · Cited by 144 · see citing works
Redford, P. S., Mayer-Barber, K. D., McNab, F. W., Stavropoulos, E., Wack, A., Sher, A., & O’Garra, A. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit424 · Cited by 136 · see citing works
Self-citationOpitz, B., Vinzing, M., van Laak, V., Schmeck, B., Heine, G., Günther, S., Preißner, R., Slevogt, H., N’Guessan, P. D., Eitel, J., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604638200 · Cited by 135 · see citing works
Lymphocytes are detrimental during the early innate immune response against Listeria monocytogenes
Carrero, J. A., Calderón, B., & Unanue, E. R. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060045 · Cited by 135 · see citing works
Richards, D. F., Fernandez, M., Caulfield, J., & Hawrylowicz, C. M. (2000) · European Journal of Immunology · doi:10.1002/1521-4141(2000)30:8 · Cited by 133 · see citing works
Cooper, A. M., Pearl, J. E., Brooks, J. V., Ehlers, S., & Orme, I. M. (2000) · Infection and Immunity · doi:10.1128/iai.68.12.6879-6882.2000 · Cited by 133 · see citing works
Kelly‐Scumpia, K. M., Scumpia, P. O., Delano, M. J., Weinstein, J. S., Cuenca, A. G., Wynn, J. L., & Moldawer, L. L. (2010) · The Journal of Experimental Medicine · doi:10.1084/jem.20091959 · Cited by 132 · see citing works
Lapenta, C., Santini, S. M., Logozzi, M., Spada, M., Andreotti, M., Pucchio, T. D., Parlato, S., & Belardelli, F. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021924 · Cited by 128 · see citing works
Rothfuchs, A. G., Gigliotti, D., Palmblad, K., Andersson, U., Wigzell, H., & Rottenberg, M. E. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.11.6453 · Cited by 128 · see citing works
Qiu, H., Fan, Y., Joyee, A. G., Wang, S., Han, X., Bai, H., Jiao, L., van Rooijen, N., & Yang, X. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.3.2092 · Cited by 123 · see citing works
Shah, S., Bohsali, A., Ahlbrand, S. E., Srinivasan, L., Rathinam, V. A. K., Vogel, S. N., Fitzgerald, K. A., Sutterwala, F. S., & Briken, V. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301331 · Cited by 123 · see citing works
Freudenberg, M. A., Merlin, T., Kalis, C., Chvatchko, Y., STÜBIG, H., & Galanos, C. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.4.1665 · Cited by 121 · see citing works
Shigeno, M., Nakao, K., Ichikawa, T., Suzuki, K., Kawakami, A., Abiru, S., Miyazoe, S., Nakagawa, Y., Ishikawa, H., Hamasaki, K., et al. (2003) · Oncogene · doi:10.1038/sj.onc.1206139 · Cited by 117 · see citing works
Bourgeois, C., Majer, O., Frohner, I. E., Lesiak-Markowicz, I., Hildering, K.-S., Glaser, W., Stockinger, S., Decker, T., Akira, S., Müller, M., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002599 · Cited by 116 · see citing works
Early type I interferon‐mediated signals on B cells specifically enhance antiviral humoral responses
Fink, K., Lang, K. S., Manjarrez‐Orduño, N., Junt, T., Senn, B. M., Holdener, M., Akira, S., Zinkernagel, R. M., & Hengartner, H. (2006) · European Journal of Immunology · doi:10.1002/eji.200635993 · Cited by 114 · see citing works
Kim, Y., Park, J., Reimer, T., Baker, D. P., Kawai, T., Kumar, H., Akira, S., Wobus, C. E., & Núñez, G. (2011) · Cell Host & Microbe · doi:10.1016/j.chom.2011.05.006 · Cited by 113 · see citing works
Haque, A., Best, S. E., Ammerdorffer, A., Desbarrieres, L., de, M. M., Amante, F. H., Rivera, F. D. L., Hertzog, P. J., Boyle, G. M., Hill, G. R., et al. (2011) · European Journal of Immunology · doi:10.1002/eji.201141539 · Cited by 111 · see citing works
The Role of Host Genetics in Susceptibility to Influenza: A Systematic Review
Horby, P., Nguyen, N., Dunstan, S. J., & Baillie, J. K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033180 · Cited by 111 · see citing works
Modulation of STAT1 protein levels: a mechanism shaping CD8 T-cell responses in vivo
Gil, M. P., Salomon, R., Louten, J., & Biron, C. A. (2005) · Blood · doi:10.1182/blood-2005-07-2834 · Cited by 110 · see citing works
Characterization of the Interferon-Producing Cell in Mice Infected with Listeria monocytogenes
Stockinger, S., Kastner, R., Kernbauer, E., Pilz, A., Westermayer, S., Reutterer, B., Soulat, D., Stengl, G., Vogl, C., Frenz, T., et al. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000355 · Cited by 109 · see citing works
Pinto, A. K., Daffis, S., Brien, J. D., Gainey, M. D., Yokoyama, W. M., Sheehan, K. C. F., MURPHY, K. M. M., Schreiber, R. D., & Diamond, M. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002407 · Cited by 107 · see citing works
Chi, B., Dickensheets, H. L., Spann, K. M., Alston, M. A., Luongo, C., Dumoutier, L., Huang, J., Renauld, J., Kotenko, S. V., Roederer, M., et al. (2006) · Journal of Virology · doi:10.1128/jvi.80.10.5032-5040.2006 · Cited by 106 · see citing works
B7-1/2 (CD80/CD86) Direct Signaling to B Cells Enhances IgG Secretion
Rau, F. C., Dieter, J. A., Luo, Z., Priest, S. O., & Baumgarth, N. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803783 · Cited by 105 · see citing works
Beta Interferon Controls West Nile Virus Infection and Pathogenesis in Mice
Lazear, H. M., Pinto, A. K., Vogt, M. R., Gale, M., & Diamond, M. (2011) · Journal of Virology · doi:10.1128/jvi.00396-11 · Cited by 104 · see citing works
Baranek, T., Manh, T. V., Alexandre, Y. O., Maqbool, M. A., Cabeza, J. Z., Tomasello, E., Crozat, K., Bessou, G., Zucchini, N., Robbins, S. H., et al. (2012) · Cell Host & Microbe · doi:10.1016/j.chom.2012.09.002 · Cited by 103 · see citing works
van Grevenynghe, J., Cubas, R. A., Noto, A., DaFonseca, S., He, Z., Peretz, Y., Filali-Mouhim, A., Dupuy, F. P., Procopio, F. A., Chomont, N., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci59211 · Cited by 100 · see citing works
Keppler, S. J., Rosenits, K., Kögl, T., Vucikuja, S., & Aichele, P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040865 · Cited by 99 · see citing works
McNab, F. W., Ewbank, J., Rajsbaum, R., Stavropoulos, E., Մարտիրոսյան, Ա., Redford, P. S., Wu, X., Graham, C. M., Saraiva, M., Tsichlis, P. N., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300146 · Cited by 96 · see citing works
Self-citationTschurtschenthaler, M., Wang, J., Fricke, C., Fritz, T. M. J., Niederreiter, L., Adolph, T. E., Sarcevic, E., Künzel, S., Offner, F. A., Kalinke, U., et al. (2014) · Gut · doi:10.1136/gutjnl-2013-305863 · Cited by 96 · see citing works
Wang, J. O., Lin, Q., Langston, H. P., & Cooper, M. D. (1995) · Immunity · doi:10.1016/1074-7613(95)90176-0 · Cited by 94 · see citing works
Recognition of yeast nucleic acids triggers a host‐protective type I interferon response
Biondo, C., Signorino, G., Costa, A., Midiri, A., Gerace, E., Galbo, R., Bellantoni, A., Malara, A., Beninati, C., Teti, G., et al. (2011) · European Journal of Immunology · doi:10.1002/eji.201141490 · Cited by 93 · see citing works
Marshall, H. D., Urban, S. L., & Welsh, R. M. (2011) · Journal of Virology · doi:10.1128/jvi.02516-10 · Cited by 93 · see citing works
Cutting Edge: IL-15-Independent NK Cell Response to Mouse Cytomegalovirus Infection
Sun, J. C.-Y., Ma, A., & Lanier, L. L. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901872 · Cited by 93 · see citing works
Kaser, A., Nagata, S., & Tilg, H. (1999) · Cytokine · doi:10.1006/cyto.1998.0484 · Cited by 91 · see citing works
Type I IFN Receptor Regulates Neutrophil Functions and Innate Immunity to Leishmania Parasites
Xin, L., Vargas‐Inchaustegui, D. A., Raimer, S., Kelly, B. C., Hu, J., Zhu, L., Sun, J., & Soong, L. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903273 · Cited by 91 · see citing works
Gil, M. P., Ploquin, M. J.-Y., Watford, W. T., Lee, S., Kim, K., Wang, X., Kanno, Y., O’Shea, J. J., & Biron, C. A. (2012) · Blood · doi:10.1182/blood-2012-05-428672 · Cited by 90 · see citing works
Khouri, R., Báfica, A. L. B., da Silva, M. D. P. P., Noronha, A., Kolb, J., Wietzerbin, J., Barral, A. M. P., Barral‐Netto, M., & Weyenbergh, J. V. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802860 · Cited by 88 · see citing works
Santodonato, L., D’Agostino, G., Nisini, R., Mariotti, S., Monque, D. M., Spada, M., Lattanzi, L., Perrone, M. P., Andreotti, M., Belardelli, F., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.10.5195 · Cited by 86 · see citing works
TLR-Dependent Induction of IFN-β Mediates Host Defense against Trypanosoma cruzi
Koga, R., Hamano, S., Kuwata, H., Atarashi, K., Ogawa, M., Hisaeda, H., Yamamoto, M., Akira, S., Himeno, K., Matsumoto, M., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.10.7059 · Cited by 86 · see citing works
Prostaglandin E2 Suppresses Lipopolysaccharide-Stimulated IFN-β Production
Xu, X. J., Reichner, J. S., Mastrofrancesco, B., Henry, W. L., & Albina, J. E. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.4.2125 · Cited by 85 · see citing works
Mack, E. A., Kallal, L. E., Demers, D. A., & Biron, C. A. (2011) · mBio · doi:10.1128/mbio.00169-11 · Cited by 84 · see citing works
de Almeida, L. A., Carvalho, N. B., Oliveira, F. S., Lacerda, T. L. S., Vasconcelos, A. C., Nogueira, L. D. L., Báfica, A. L. B., Silva, A. M., & Oliveira, S. C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023135 · Cited by 83 · see citing works
Voisine, C., Mastelic, B., Sponaas, A., & Langhorne, J. (2009) · International Journal for Parasitology · doi:10.1016/j.ijpara.2009.11.005 · Cited by 81 · see citing works
Purtha, W. E., Chachu, K. A., Virgin, H. W., & Diamond, M. (2008) · Journal of Virology · doi:10.1128/jvi.01646-08 · Cited by 81 · see citing works
Interferons Direct an Effective Innate Response to Legionella pneumophila Infection
Plumlee, C. R., Lee, C., Beg, A. A., Decker, T., Shuman, H. A., & Schindler, C. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.018283 · Cited by 80 · see citing works
Schiavoni, G., Mauri, C., Carlei, D., Belardelli, F., Pastoris, M. C., & Proietti, E. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.2.1266 · Cited by 79 · see citing works
Recombinant Human IFN-α Inhibits Cerebral Malaria and Reduces Parasite Burden in Mice
Vigário, A. M., Belnoue, E., Grüner, A. C., Mauduit, M., Kayibanda, M., Deschemin, J., Marussig, M., Snounou, G., Mazier, D., Gresser, I., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.10.6416 · Cited by 77 · see citing works
Ramos, H. J., Davis, A. M., Cole, A. G., Schatzle, J. D., Forman, J., & Farrar, J. D. (2009) · Blood · doi:10.1182/blood-2008-11-188458 · Cited by 75 · see citing works
Poly I:C Enhances Susceptibility to Secondary Pulmonary Infections by Gram-Positive Bacteria
Tian, X., Xu, F., Lung, W. Y., Meyerson, C., Ghaffari, A. A., Cheng, G., & Deng, J. C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041879 · Cited by 75 · see citing works
McNally, B. A., Ye, F., Willette, M., & Flaño, E. (2013) · Journal of Virology · doi:10.1128/jvi.02423-13 · Cited by 72 · see citing works
Activation Mechanisms of Natural Killer Cells during Influenza Virus Infection
Hwang, I., Scott, J. M., Kakarla, T., Duriancik, D. M., Choi, S., Cho, C., Lee, T., Park, H., French, A. R., Beli, E., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051858 · Cited by 72 · see citing works
Natural and recombinant interferons inhibit epithelial cell invasion by Shigella spp
Niesel, D. W., Hess, C. B., Cho, Y. J., Klimpel, K. D., & Klimpel, G. R. (1986) · Infection and Immunity · doi:10.1128/iai.52.3.828-833.1986 · Cited by 70 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Galluzzi, L., Vitale, I., Aaronson, S. A., Abrams, J. M., Adam, D., Agostinis, P., Alnemri, E. S., Altucci, L., Amelio, I., Andrews, D. W., et al. (2018) · Cell Death & Differentiation · doi:10.1038/s41418-017-0012-4 · Cited by 6,680 · see citing works
Immunogenic cell death in cancer and infectious disease
Galluzzi, L., Buqué, A., Kepp, O., Zitvogel, L., & Kroemer, G. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2016.107 · Cited by 3,119 · see citing works
CD8 T Cell Exhaustion During Chronic Viral Infection and Cancer
McLane, L. M., Abdel-Hakeem, M. S., & Wherry, E. J. (2019) · Annual Review of Immunology · doi:10.1146/annurev-immunol-041015-055318 · Cited by 1,973 · see citing works
RIG-I-like receptors: their regulation and roles in RNA sensing
Rehwinkel, J., & Gack, M. U. (2020) · Nature reviews. Immunology · doi:10.1038/s41577-020-0288-3 · Cited by 1,703 · see citing works
Channappanavar, R., Fehr, A. R., Vijay, R., Mack, M., Zhao, J., Meyerholz, D. K., & Perlman, S. M. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.01.007 · Cited by 1,400 · see citing works
Type I interferons in anticancer immunity
Zitvogel, L., Galluzzi, L., Kepp, O., Smyth, M. J., & Kroemer, G. (2015) · Nature Reviews Immunology · doi:10.1038/nri3845 · Cited by 1,305 · see citing works
Consensus guidelines for the definition, detection and interpretation of immunogenic cell death
Galluzzi, L., Vitale, I., Warren, S., Adjemian, S., Agostinis, P., Buqué, A., Chan, T. A.-T., Coukos, G., Demaria, S., Deutsch, É., et al. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2019-000337 · Cited by 1,151 · see citing works
Detection of immunogenic cell death and its relevance for cancer therapy
Fucikova, J., Kepp, O., Kasikova, L., Petroni, G., Yamazaki, T., Liu, P., Zhao, L., Spisek, R., Kroemer, G., & Galluzzi, L. (2020) · Cell Death & Disease · doi:10.1038/s41419-020-03221-2 · Cited by 1,138 · see citing works
Mitochondrial DNA in innate immune responses and inflammatory pathology
West, A. P., & Shadel, G. S. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.21 · Cited by 1,115 · see citing works
IL-10 Family Cytokines IL-10 and IL-22: from Basic Science to Clinical Translation
Ouyang, W., & O’Garra, A. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.020 · Cited by 1,084 · see citing works
Self-citationThe senescence-associated secretory phenotype and its physiological and pathological implications
Wang, B., Han, J., Elisseeff, J. H., & Demaria, M. (2024) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-024-00727-x · Cited by 948 · see citing works
Qi, F., Qian, S., Zhang, S., & Zhang, Z. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.03.044 · Cited by 905 · see citing works
Autophagy in inflammation, infection, and immunometabolism
Deretic, V. (2021) · Immunity · doi:10.1016/j.immuni.2021.01.018 · Cited by 862 · see citing works
Control of Metastasis by NK Cells
López‐Soto, A., Gonzalez, S. R., Smyth, M. J., & Galluzzi, L. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.06.009 · Cited by 730 · see citing works
Therapeutic strategies for COVID-19: progress and lessons learned
Li, G., Hilgenfeld, R., Whitley, R. J., & Clercq, E. D. (2023) · Nature Reviews Drug Discovery · doi:10.1038/s41573-023-00672-y · Cited by 691 · see citing works
The dual nature of type I and type II interferons
Lee, A. J., & Ashkar, A. A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02061 · Cited by 690 · see citing works
The Role of Astrocytes in CNS Inflammation
Giovannoni, F., & Quintana, F. J. (2020) · Trends in Immunology · doi:10.1016/j.it.2020.07.007 · Cited by 651 · see citing works
The hallmarks of successful anticancer immunotherapy
Galluzzi, L., Chan, T. A., Kroemer, G., Wolchok, J. D., & López-Soto, A. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aat7807 · Cited by 575 · see citing works
Type I interferon response drives neuroinflammation and synapse loss in Alzheimer disease
Roy, E. R., Wang, B., Wan, Y.-W., Chiu, G., Cole, A., Yin, Z., Propson, N. E., Xu, Y., Jankowsky, J. L., Liu, Z., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci133737 · Cited by 563 · see citing works
Growth of Mycobacterium tuberculosis in vivo segregates with host macrophage metabolism and ontogeny
Huang, L., Nazarova, E. V., Tan, S., Liu, Y., & Russell, D. G. (2018) · The Journal of Experimental Medicine · doi:10.1084/jem.20172020 · Cited by 550 · see citing works
Galani, I.-E., Rovina, N., Lampropoulou, V., Triantafyllia, V., Manioudaki, M., Pavlos, E., Koukaki, E., Fragkou, P. C., Panou, V., Rapti, V., et al. (2021) · Nature Immunology · doi:10.1038/s41590-020-00840-x · Cited by 503 · see citing works
LINE1 Derepression in aged wild-type and SIRT6-deficient mice drives inflammation
Simon, M., Van Meter, M., Ablaeva, J., Ke, Z., Gonzalez, R. S., Taguchi, T., De Cecco, M., Leonova, K. I., Kogan, V., Helfand, S. L., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.02.014 · Cited by 498 · see citing works
TORC1 inhibition enhances immune function and reduces infections in the elderly
Mannick, J. B., Morris, M., Hockey, H.-U. P., Roma, G., Beibel, M., Kulmatycki, K., Watkins, M., Shavlakadze, T., Zhou, W., Quinn, D., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aaq1564 · Cited by 496 · see citing works
Type I and III interferons disrupt lung epithelial repair during recovery from viral infection
Major, J., Crotta, S., Llorian, M., McCabe, T. M., Gad, H. H., Priestnall, S. L., Hartmann, R., & Wack, A. (2020) · Science · doi:10.1126/science.abc2061 · Cited by 488 · see citing works
Self-citationUbiquitin signaling in immune responses
Hu, H., & Sun, S. (2016) · Cell Research · doi:10.1038/cr.2016.40 · Cited by 481 · see citing works
Lee, Y., Jeong, M., Park, J., Jung, H., & Lee, H. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-01086-x · Cited by 477 · see citing works
Galani, I. E., Triantafyllia, V., Eleminiadou, E.-E., Koltsida, O., Stavropoulos, A., Manioudaki, M., Thanos, D., Doyle, S. E., Kotenko, S. V., Thanopoulou, K., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.04.025 · Cited by 464 · see citing works
The role of itaconate in host defense and inflammation
Peace, C. G., & O’Neill, L. A. J. (2022) · Journal of Clinical Investigation · doi:10.1172/jci148548 · Cited by 452 · see citing works
Cytokines and Chemokines inMycobacterium tuberculosisInfection
Domingo-Gonzalez, R., Prince, O. A., Cooper, A. M., & Khader, S. A. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.tbtb2-0018-2016 · Cited by 413 · see citing works
Lessons from the host defences of bats, a unique viral reservoir
Irving, A. T., Ahn, M., Goh, G., Anderson, D. E., & Wang, L. (2021) · Nature · doi:10.1038/s41586-020-03128-0 · Cited by 413 · see citing works
Zika Virus Causes Testis Damage and Leads to Male Infertility in Mice
Ma, W., Li, S., Ma, S., Jia, L., Zhang, F., Zhang, Y., Zhang, J., Wong, G., Zhang, S., Lu, X., et al. (2016) · Cell · doi:10.1016/j.cell.2016.11.016 · Cited by 404 · see citing works
Sensing of HSV-1 by the cGAS-STING pathway in microglia orchestrates antiviral defence in the CNS
Reinert, L. S., Lopušná, K., Winther, H., Sun, C., Thomsen, M. K., Nandakumar, R., Mogensen, T. H., Meyer, M., Vægter, C., Nyengaard, J. R., et al. (2016) · Nature Communications · doi:10.1038/ncomms13348 · Cited by 397 · see citing works
Pathogenesis of HIV-1 and Mycobacterium tuberculosis co-infection
Bell, L. C. K., & Noursadeghi, M. (2017) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.128 · Cited by 394 · see citing works
Combinatorial Strategies for the Induction of Immunogenic Cell Death
Bezu, L., Gomes-da-Silva, L. C., Dewitte, H., Breckpot, K., Fucikova, J. P., Špíšek, R., Galluzzi, L., Kepp, O., & Kroemer, G. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00187 · Cited by 389 · see citing works
ESX secretion systems: mycobacterial evolution to counter host immunity
Gröschel, M. I., Sayes, F., Simeone, R., Majlessi, L., & Brosch, R. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.131 · Cited by 382 · see citing works
Guarding the frontiers: the biology of type III interferons
Wack, A., Terczyńska‐Dyla, E., & Hartmann, R. (2015) · Nature Immunology · doi:10.1038/ni.3212 · Cited by 363 · see citing works
Self-citationOrganoids in immunological research
Bar-Ephraim, Y. E., Kretzschmar, K., & Clevers, H. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-019-0248-y · Cited by 361 · see citing works
SARS-CoV-2, COVID-19 and the aging immune system
Bartleson, J. M., Radenkovic, D., Covarrubias, A. J., Furman, D., Winer, D. A., & Verdin, E. (2021) · Nature Aging · doi:10.1038/s43587-021-00114-7 · Cited by 359 · see citing works
Microglia in Retinal Degeneration
Rashid, K., Akhtar‐Schäfer, I., & Langmann, T. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01975 · Cited by 354 · see citing works
Caspases Connect Cell-Death Signaling to Organismal Homeostasis
Galluzzi, L., López-Soto, A., Kumar, S., & Kroemer, G. (2016) · Immunity · doi:10.1016/j.immuni.2016.01.020 · Cited by 350 · see citing works
Karki, R., Lee, S., Mall, R., Nagakannan, P., Wang, Y., Sharma, B. R., Malireddi, R. K. S., Yang, D., Trifkovic, S., Steele, J. A., et al. (2022) · Science Immunology · doi:10.1126/sciimmunol.abo6294 · Cited by 348 · see citing works
Tumor-derived IFN triggers chronic pathway agonism and sensitivity to ADAR loss
Liu, H., Golji, J., Brodeur, L. K., Chung, F. S., Chen, J. T., deBeaumont, R. S., Bullock, C., Jones, M. D., Kerr, G., Li, L., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0302-5 · Cited by 346 · see citing works
Three decades of messenger RNA vaccine development
Verbeke, R., Lentacker, I., De Smedt, S. C., & Dewitte, H. (2019) · Nano Today · doi:10.1016/j.nantod.2019.100766 · Cited by 342 · see citing works
T Cell Dysfunction in Cancer Immunity and Immunotherapy
Xia, A., Zhang, Y., Jiang, X., Yin, T., & Lu, X. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01719 · Cited by 338 · see citing works
Type 1 Interferons Induce Changes in Core Metabolism that Are Critical for Immune Function
Wu, D., Sanin, D. E., Everts, B., Chen, Q., Qiu, J., Buck, M. D., Patterson, A. E., Smith, A. M., Chang, C., Liu, Z., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.06.006 · Cited by 331 · see citing works
Regulation of type I interferon signaling in immunity and inflammation: A comprehensive review
Chen, K., Liu, J., & Cao, X. (2017) · Journal of Autoimmunity · doi:10.1016/j.jaut.2017.03.008 · Cited by 313 · see citing works
A Balancing Act: MDA5 in Antiviral Immunity and Autoinflammation
Dias, A. G., Sampaio, N. G., & Rehwinkel, J. (2018) · Trends in Microbiology · doi:10.1016/j.tim.2018.08.007 · Cited by 309 · see citing works
Inflammatory signaling in human tuberculosis granulomas is spatially organized
Marakalala, M. J., Raju, R. M., Sharma, K., Zhang, Y. J., Eugenín, E. A., Prideaux, B., Daudelin, I. B., Chen, P., Booty, M. G., Kim, J. H., et al. (2016) · Nature Medicine · doi:10.1038/nm.4073 · Cited by 305 · see citing works
Emerging roles of innate and adaptive immunity in Alzheimer’s disease
Chen, X., & Holtzman, D. M. (2022) · Immunity · doi:10.1016/j.immuni.2022.10.016 · Cited by 297 · see citing works
New fronts emerge in the influenza cytokine storm
Guo, X.-Z. J., & Thomas, P. G. (2017) · Seminars in Immunopathology · doi:10.1007/s00281-017-0636-y · Cited by 295 · see citing works
Cooperative sensing of mitochondrial DNA by ZBP1 and cGAS promotes cardiotoxicity
Lei, Y., VanPortfliet, J. J., Chen, Y., Bryant, J. D., Li, Y., Fails, D., Torres-Odio, S., Ragan, K. B., Deng, J., Mohan, A., et al. (2023) · Cell · doi:10.1016/j.cell.2023.05.039 · Cited by 292 · see citing works
Commensal Microbiota Modulation of Natural Resistance to Virus Infection
Stefan, K. L., Kim, M. V., Iwasaki, A., & Kasper, D. L. (2020) · Cell · doi:10.1016/j.cell.2020.10.047 · Cited by 290 · see citing works
Regulation of cGAS–STING signalling and its diversity of cellular outcomes
Zhang, Z., & Zhang, C. (2025) · Nature Reviews Immunology · doi:10.1038/s41577-024-01112-7 · Cited by 287 · see citing works
Methyltransferase SETD2-Mediated Methylation of STAT1 Is Critical for Interferon Antiviral Activity
Chen, K., Liu, J., Liu, S., Meng, X., Zhang, X., Han, D., Jiang, Y., Wang, C., & Cao, X. (2017) · Cell · doi:10.1016/j.cell.2017.06.042 · Cited by 283 · see citing works
Olagnier, D., Brandtoft, A. M., Gunderstofte, C., Villadsen, N. L., Krapp, C., Thielke, A. L., Laustsen, A., Peri, S., Hansen, A. L., Bonefeld, L., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05861-7 · Cited by 282 · see citing works
Deriu, E., Boxx, G. M., He, X., Pan, C., Benavidez, S. D., Cen, L., Rozengurt, N., Shi, W., & Cheng, G. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005572 · Cited by 280 · see citing works
The Role of Interferons in Inflammation and Inflammasome Activation
Kopitar‐Jerala, N. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00873 · Cited by 280 · see citing works
Pisu, D., Huang, L., Grenier, J., & Russell, D. (2020) · Cell Reports · doi:10.1016/j.celrep.2019.12.033 · Cited by 230 · see citing works
HIV-1 and interferons: who's interfering with whom?
Doyle, T., Goujon, C., & Malim, M. H. (2015) · Nature Reviews Microbiology · doi:10.1038/nrmicro3449 · Cited by 280 · see citing works
Direct Antiviral Mechanisms of Interferon-Gamma
Kang, S., Brown, H. M., & Hwang, S. (2018) · Immune Network · doi:10.4110/in.2018.18.e33 · Cited by 280 · see citing works
Type I interferons in tuberculosis: Foe and occasionally friend
Moreira-Teixeira, L., Mayer-Barber, K. D., Sher, A., & O’Garra, A. (2018) · The Journal of Experimental Medicine · doi:10.1084/jem.20180325 · Cited by 273 · see citing works
Self-citationHost-directed immunotherapy of viral and bacterial infections: past, present and future
Wallis, R. S., O’Garra, A., Sher, A., & Wack, A. (2022) · Nature reviews. Immunology · doi:10.1038/s41577-022-00734-z · Cited by 268 · see citing works
Self-citationGasdermin D Restrains Type I Interferon Response to Cytosolic DNA by Disrupting Ionic Homeostasis
Banerjee, I., Behl, B., Mendonça, M. S. A., Shrivastava, G., Russo, A. J., Ménoret, A., Ghosh, A., Vella, A. T., Vanaja, S. K., Sarkar, S. N., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.07.006 · Cited by 263 · see citing works
The Impact of Estrogens and Their Receptors on Immunity and Inflammation during Infection
Harding, A. T., & Heaton, N. S. (2022) · Cancers · doi:10.3390/cancers14040909 · Cited by 261 · see citing works
The lung microbiome regulates brain autoimmunity
Hosang, L., Canals, R. C., van der Flier, F. J., Hollensteiner, J., Daniel, R., Flügel, A., & Odoardi, F. (2022) · Nature · doi:10.1038/s41586-022-04427-4 · Cited by 260 · see citing works
Toxoplasma gondii infection and its implications within the central nervous system
Matta, S. K., Rinkenberger, N., Dunay, I. R., & Sibley, L. D. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-021-00518-7 · Cited by 259 · see citing works
Vacchelli, E., Eggermont, A. M. M., Sautès‐Fridman, C., Galon, J., Zitvogel, L., Kroemer, G., & Galluzzi, L. (2013) · OncoImmunology · doi:10.4161/onci.24612 · Cited by 255 · see citing works
Immunotoxicity mechanisms of perfluorinated compounds PFOA and PFOS
Liang, L., Pan, Y., Bin, L., Liu, Y., Huang, W., Li, R., & Lai, K. P. (2021) · Chemosphere · doi:10.1016/j.chemosphere.2021.132892 · Cited by 252 · see citing works
Cytosolic DNA Sensing in Organismal Tumor Control
Vanpouille-Box, C., Demaria, S., Formenti, S. C., & Galluzzi, L. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.05.013 · Cited by 250 · see citing works
STING inhibits the reactivation of dormant metastasis in lung adenocarcinoma
Hu, J. Y., Rivera, F. J. S., Wang, Z., Johnson, G. N., Ho, Y.-J., Ganesh, K., Umeda, S., Gan, S., Mujal, A. M., Delconte, R. B., et al. (2023) · Nature · doi:10.1038/s41586-023-05880-5 · Cited by 252 · see citing works
Dectin-1 Signaling Update: New Perspectives for Trained Immunity
Mata-Martínez, P., Bergón-Gutiérrez, M., & del Fresno, C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.812148 · Cited by 243 · see citing works
Type I interferons in viral control and immune regulation
Teijaro, J. R. (2016) · Current Opinion in Virology · doi:10.1016/j.coviro.2016.01.001 · Cited by 242 · see citing works
The molecular basis for differential type I interferon signaling
Schreiber, G. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.r116.774562 · Cited by 240 · see citing works
Singhania, A., Verma, R., Graham, C. M., Lee, J., Tran, T. A. T., Richardson, M., Lécine, P., Leissner, P., Berry, M. P. R., Wilkinson, R. J., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04579-w · Cited by 235 · see citing works
Self-citationA molecular switch from STAT2-IRF9 to ISGF3 underlies interferon-induced gene transcription
Platanitis, E., Demiroz, D., Schneller, A., Fischer, K., Capelle, C., Hartl, M., Gossenreiter, T., Müller, M., Novatchkova, M., & Decker, T. (2019) · Nature Communications · doi:10.1038/s41467-019-10970-y · Cited by 233 · see citing works
The Impact of Radiation-Induced DNA Damage on cGAS-STING-Mediated Immune Responses to Cancer
Storozynsky, Q. T., & Hitt, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228877 · Cited by 233 · see citing works
The Mechanism behind Influenza Virus Cytokine Storm
Gu, Y., Zuo, X., Zhang, S., Ouyang, Z., Jiang, S., Wang, F., & Wang, G. (2021) · Viruses · doi:10.3390/v13071362 · Cited by 233 · see citing works
Moreira-Teixeira, L., Stimpson, P., Stavropoulos, E., Hadebe, S., Chakravarty, P., Ιωάννου, Μ., Aramburu, I. V., Herbert, E., Priestnall, S. L., Suárez‐Bonnet, A., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19412-6 · Cited by 232 · see citing works
Self-citationMetagenomic Sequencing Detects Respiratory Pathogens in Hematopoietic Cellular Transplant Patients
Langelier, C., Zinter, M. S., Kalantar, K., Yanik, G. A., Christenson, S. A., O’Donovan, B. D., White, C. V., Wilson, M. R., Sapru, A., Dvorak, C. C., et al. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201706-1097le · Cited by 231 · see citing works
Coronavirus Disease 2019 and Stroke: Clinical Manifestations and Pathophysiological Insights
Divani, A. A., Andalib, S., Napoli, M. D., Lattanzi, S., Hussain, M. S., Biller, J., McCullough, L. D., Azarpazhooh, M. R., Seletska, A., Mayer, S. A., et al. (2020) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2020.104941 · Cited by 231 · see citing works
Klein, T., Eckhard, U., Dufour, A., Solis, N., & Overall, C. M. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00120 · Cited by 229 · see citing works
Inflammatory Cytokines in Cancer: Comprehensive Understanding and Clinical Progress in Gene Therapy
Lan, T., Chen, L., & Wei, X. (2021) · Cells · doi:10.3390/cells10010100 · Cited by 229 · see citing works
Coinfections and their molecular consequences in the porcine respiratory tract
Saade, G. A., Deblanc, C., Bougon, J., Marois‐Créhan, C., Fablet, C., Auray, G., Belloc, C., Leblanc-Maridor, M., Gagnon, C. A., Zhu, J., et al. (2020) · Veterinary Research · doi:10.1186/s13567-020-00807-8 · Cited by 228 · see citing works
Christensen, M. H., Jensen, S. B., Miettinen, J. J., Luecke, S., Prabakaran, T., Reinert, L. S., Mettenleiter, T. C., Chen, Z. J., Knipe, D. M., Sandri-Goldin, R. M., et al. (2016) · The EMBO Journal · doi:10.15252/embj.201593458 · Cited by 227 · see citing works
The long noncoding RNA Lnczc3h7a promotes a TRIM25-mediated RIG-I antiviral innate immune response
Lin, H., Jiang, M., Liu, L., Yang, Z., Ma, Z., Liu, S., Ma, Y., Zhang, L., & Cao, X. (2019) · Nature Immunology · doi:10.1038/s41590-019-0379-0 · Cited by 224 · see citing works
Viral Innate Immune Evasion and the Pathogenesis of Emerging RNA Virus Infections
Nelemans, T., & Kikkert, M. (2019) · Viruses · doi:10.3390/v11100961 · Cited by 224 · see citing works
Systemic vaccination induces CD8+ T cells and remodels the tumor microenvironment
Baharom, F., Ramirez-Valdez, R. A., Khalilnezhad, A., Khalilnezhad, S., Dillon, M., Hermans, D., Fussell, S. C., Tobin, K. K. S., Dutertre, C., Lynn, G. M., et al. (2022) · Cell · doi:10.1016/j.cell.2022.10.006 · Cited by 220 · see citing works
Eisenreich, W., Rudel, T., Heesemann, J., & Goebel, W. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00042 · Cited by 218 · see citing works
Brain-resident memory T cells represent an autonomous cytotoxic barrier to viral infection
Steinbach, K., Vincenti, I., Kreutzfeldt, M., Pagé, N., Muschaweckh, A., Wagner, I., Drexler, I., Pinschewer, D. D., Korn, T., & Merkler, D. (2016) · The Journal of Experimental Medicine · doi:10.1084/jem.20151916 · Cited by 212 · see citing works
Extracellular Vesicle RNA: A Universal Mediator of Microbial Communication?
Tsatsaronis, J. A., Franch-Arroyo, S., Resch, U., & Charpentier, E. (2018) · Trends in Microbiology · doi:10.1016/j.tim.2018.02.009 · Cited by 210 · see citing works
Jin, S., Tian, S., Luo, M., Xie, W., Liu, T., Duan, T., Wu, Y., & Cui, J. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.09.005 · Cited by 207 · see citing works
Mayer-Barber, K. D., & Yan, B. (2016) · Cellular and Molecular Immunology · doi:10.1038/cmi.2016.25 · Cited by 206 · see citing works
Self-citationGalvão, I., Sugimoto, M. A., Vago, J. P., Machado, M. G., & Sousa, L. P. (2018) · Springer eBooks · doi:10.1007/978-3-319-77658-3_1 · Cited by 202 · see citing works
Mitochondrial dysfunction as a trigger of innate immune responses and inflammation
West, A. P. (2017) · Toxicology · doi:10.1016/j.tox.2017.07.016 · Cited by 199 · see citing works
Parasite Recognition and Signaling Mechanisms in Innate Immune Responses to Malaria
Gowda, D. C., & Wu, X. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.03006 · Cited by 197 · see citing works
Function of HNRNPC in breast cancer cells by controlling the dsRNA‐induced interferon response
Wu, Y., Zhao, W., Liu, Y., Tan, X., Li, X., Zou, Q., Xiao, Z., Xu, H., Wang, Y., & Yang, X. (2018) · The EMBO Journal · doi:10.15252/embj.201899017 · Cited by 195 · see citing works
Peripheral Nervous System Manifestations Associated with COVID-19
Andalib, S., Biller, J., Napoli, M. D., Moghimi, N., McCullough, L. D., Rubiños, C., Nobleza, C. O., Azarpazhooh, M. R., Catanese, L., Elicer, I., et al. (2021) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-021-01102-5 · Cited by 194 · see citing works
TREM2 dependent and independent functions of microglia in Alzheimer’s disease
Hou, J., Chen, Y., Grajales-Reyes, G., & Colonna, M. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00588-y · Cited by 191 · see citing works
The interplay of immunology and cachexia in infection and cancer
Baazim, H., Antonio-Herrera, L., & Bergthaler, A. (2021) · Nature reviews. Immunology · doi:10.1038/s41577-021-00624-w · Cited by 188 · see citing works
COVID-19: Unmasking Emerging SARS-CoV-2 Variants, Vaccines and Therapeutic Strategies
Raman, R., Patel, K. J., & Ranjan, K. (2021) · Biomolecules · doi:10.3390/biom11070993 · Cited by 186 · see citing works
- Authors
- McNab, F., Mayer-Barber, K., Sher, A., Wack, A., & O'Garra, A.
- Affiliations
- GlaxoSmithKline (United Kingdom) (GB)
- National Institutes of Health (US)
- National Institute for Medical Research (GB)
- Venue
- Nature Reviews Immunology
- Published
- 2015-01-23
- Volume
- 15
- Issue
- 2
- Pages
- 87-103
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- PMC
- PMC7162685
- OpenAlex
- W2091129202
- Cited by
- 2,780
- References
- 238
- Citations by year
- 2026: 263 · 2025: 333 · 2024: 364 · 2023: 330 · 2022: 330 · 2021: 307 · 2020: 194 · 2019: 160 · 2018: 166 · 2017: 169 · 2016: 119 · 2015: 44 · 2013: 1
- FWCI
- 15.67
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Wellcome Trust (FC001126)
- Francis Crick Institute (10206, 10126)
- Cancer Research UK (FC001126)
- National Institutes of Health
- Medical Research Council (U117597139, U117565642)
- National Institute of Allergy and Infectious Diseases
- FP7 Ideas: European Research Council (294682)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Health Sciences › Medicine › Oncology › Cytokine Signaling Pathways and Interactions
- Keywords
- type I interferon, innate immunity, viral infection, bacterial infection, parasitic infection, fungal infection, immunopathology, influenza virus, lymphocytic choriomeningitis virus, chronic viral infection, immunosuppression, B cell response, macrophage activation, Listeria monocytogenes, Mycobacterium tuberculosis, prostaglandin E2, interleukin-1, host defense
- MeSH terms
- Animals, Bacterial Infections, Communicable Diseases, Humans, Interferon Type I, Mycoses, Parasitic Diseases, Virus Diseases, Signal Transduction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review